The goal of this randomized controlled trial is to investigate the effect of injection of autologous amniotic fluid in the healing of the scar of cesarean section among high-risk population. Investigator's aim is to know : quality of wound healing, rate of infection and time needed for complete healing. Participants will be divided into two groups. All participants will undergo cesarean section. We will inject autologous amniotic fluid in the edges of the wound during skin closure in half of the participants. Wound healing will be assessed at 1st, 2nd and 6th week postoperatively.
After surgery, participants will be observed along 6 weeks (at 1, 2 and 6 weeks intervals) and scars will be assessed regarding color, thickness, pliability and presence of exudate.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
108
10 cc of amniotic fluid aspirated after opening uterine incision in cesarean section, then Injected in edges of skin before closure
conventional closure of skin
kasr Al Aini, Faculty of Medicine, Cairo University
Cairo, Old Cairo, Egypt
Quality of wound healing
Scars will be assessed objectively regarding Color, Thickness, Pliability, Exudate in participants and controls
Time frame: 1,2,6 weeks postoperative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.